Dietary salt restriction increases plasma lipoprotein and inflammatory marker concentrations in hypertensive patients
| Contribuinte(s) |
UNIVERSIDADE DE SÃO PAULO |
|---|---|
| Data(s) |
19/10/2012
19/10/2012
2008
|
| Resumo |
Background: Dietary salt restriction has been reported to adversely modify the plasma lipoprotein profile in hypertensive and in normotensive subjects. We investigated the effects of the low sodium intake (LSI) on the plasma lipoprotein profile and on inflammation and thrombosis biomarkers during the fasting and postprandial periods. Methods: Non-obese, non-treated hypertensive adults (n=41) were fed strictly controlled diets. An initial week on a control diet (CID, Na=160 mmol/day) was followed by 3 weeks on LSI (Na=60mmol/day). At admission and on the last day of each period, the 24-h ambulatory blood pressure was monitored and blood was drawn after an overnight fasting period and after a fat-rich test meal. Results: The dietary adherence was confirmed by 24-h urinary sodium excretion. Fasting triglyceride (TG), chylomicron-cholesterol, hsC-reactive protein (CRP), tumor necrosis factor-a (TNF-alpha). interleukin-6 (IL-6) concentrations, renin activity, aldosterone, insulin, and homeostasis model assessment insulin resistance (HOMA-IR) Values were higher, but non-esterified fatty acids (NEFA) were lower on LSI than on CD. For LSI, areas under the curve (AUC) of TG, chylomicron-cholesterol, apoB and the cholesterol/apoB ratio were increased, whereas AUC-NEFA was lowered. LSI did not modify body weight, hematocrit, fasting plasma cholesterol, glucose, adiponectin, leptin, fibrinogen and factor VII (FVII), and AUC of lipoprotein lipase and of lipoprotein remnants. Conclusion: LSI induced alterations in the plasma lipoproteins and in inflammatory markers that are common features of the metabolic syndrome. (C) 2008 Elsevier Ireland Ltd. All rights reserved. FAPESP (Sao Paulo Research Foundation)[00/04249-3] AMC and FCS[01/08302-9] AMC and FCS[00/14918-8] CNPq (Brazilian National Research Council ECRQ) LIMHC/FMUSP (Medical Investigation Laboratories, Hospital das Clinicas/Faculty of Medical Sciences of University of Sao Paulo) |
| Identificador |
ATHEROSCLEROSIS, v.200, n.2, p.410-416, 2008 0021-9150 http://producao.usp.br/handle/BDPI/21630 10.1016/j.atherosclerosis.2007.12.034 |
| Idioma(s) |
eng |
| Publicador |
ELSEVIER IRELAND LTD |
| Relação |
Atherosclerosis |
| Direitos |
restrictedAccess Copyright ELSEVIER IRELAND LTD |
| Palavras-Chave | #Sodium diet #Remnant lipoproteins #Postprandial lipoproteins #Arterial hypertension #Inflammatory markers #Metabolic syndrome #C-REACTIVE PROTEIN #SODIUM CHLORIDE RESTRICTION #CORONARY-HEART-DISEASE #E-DEFICIENT MICE #MIDDLE-AGED MEN #INSULIN SENSITIVITY #ANGIOTENSIN-II #WISTAR RATS #COAGULATION-FACTORS #LIPID CONCENTRATION #Peripheral Vascular Disease |
| Tipo |
article original article publishedVersion |